Think of Enterprise Value as the theoretical takeover price. It is more comprehensive than market capitalization (Market Cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.
EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Viva Biotech Holdings's Enterprise Value is €293.6 Mil.
Viva Biotech Holdings's EBIT for the trailing twelve months (TTM) ended in Dec. 2025 was €43.0 Mil. Therefore, Viva Biotech Holdings's EV-to-EBIT ratio for today is 6.83.
EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA. As of today, Viva Biotech Holdings's Enterprise Value is €293.6 Mil.
Viva Biotech Holdings's EBITDA for the trailing twelve months (TTM) ended in Dec. 2025 was €68.5 Mil. Therefore, Viva Biotech Holdings's EV-to-EBITDA ratio for today is 4.28.
*** Please note that the current Enterprise Value is calculated using the current market capitalization and the most recently available financial data. If key financial fields—Long-Term Debt & Capital Lease Obligation and Short-Term Debt & Capital Lease Obligation—are recorded as null in the latest reporting period, our data vendor will default to using data from the prior period with valid entries.
Viva Biotech Holdings (FRA:VB0) Enterprise Value Explanation
When an investor buy a company, the investor needs to pay not only the common shares, he/she also needs to pay the shareholders of Preferred Stocks. He also assumes the debt of the company, and receives the cash on the company's balance sheet.
If a company has more cash than debt, the investor actually pays less than the Market Cap because he immediately owns the cash once the transaction goes through.
The market value of Preferred Stock needs to be added to the market value of common stocks in the calculation of Enterprise Value.
For the companies with the same Market Cap, the smaller the Enterprise Value is, the cheaper the company is.
Enterprise Value can be negative when the company's net cash is more than its Market Cap. In this case the investor is basically getting the company for free and get paid for that.
1. EV-to-EBIT is calculated as Enterprise Value divided by its EBIT.
Viva Biotech Holdings's current Enterprise Value is €293.6 Mil.
For company reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data. Viva Biotech Holdings's EBIT for the trailing twelve months (TTM) ended in Dec. 2025 was €43.0 Mil.
2. EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA.
Viva Biotech Holdings's EV-to-EBITDA for today is:
Viva Biotech Holdings's current Enterprise Value is €293.6 Mil.
For company reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data. Viva Biotech Holdings's EBITDA for the trailing twelve months (TTM) ended in Dec. 2025 was €68.5 Mil.
Viva Biotech Holdings's current Enterprise Value is €293.6 Mil.
For company reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data. Viva Biotech Holdings's Revenue for the trailing twelve months (TTM) ended in Dec. 2025 was €209.3 Mil.
Viva Biotech Holdings's current Enterprise Value is €293.6 Mil.
For company reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data. Viva Biotech Holdings's Cash Flow from Operations for the trailing twelve months (TTM) ended in Dec. 2025 was €28.1 Mil.
Viva Biotech Holdings's current Enterprise Value is €293.6 Mil.
For company reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data. Viva Biotech Holdings's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2025 was €13.3 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Viva Biotech Holdings Enterprise Value Related Terms
Viva Biotech Holdings Enterprise Value Historical Data
* Premium members only.
The historical data trend for Viva Biotech Holdings's Enterprise Value can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
FRA:VB0 vs VRTX, REGN, ALNY: Enterprise Value Comparison
For the Biotechnology subindustry, Viva Biotech Holdings's Enterprise Value, along with its competitors' market caps and Enterprise Value data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Viva Biotech Holdings Enterprise Value vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Viva Biotech Holdings's Enterprise Value distribution charts can be found below:
* The bar in red indicates where Viva Biotech Holdings's Enterprise Value falls into.
Viva Biotech Holdings Enterprise Value Calculation
Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.
Viva Biotech Holdings's Enterprise Value for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Viva Biotech Holdings (FRA:VB0) has a Enterprise Value of €293.6 Mil as of Jun. 29, 2026. Enterprise value equals the sum of market cap, debt and preferred shares less cash and equivalents. View historical data on Viva Biotech Holdings and its competitors.
Is Viva Biotech Holdings' Enterprise Value too high?
Viva Biotech Holdings' current Enterprise Value is €293.6 Mil. Overall, Viva Biotech Holdings has a GF Score™ of 47/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Viva Biotech Holdings' Enterprise Value compare to VRTX and REGN?
Viva Biotech Holdings' Enterprise Value of €293.6 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Enterprise Value for a Biotechnology company?
A good Enterprise Value depends on the Biotechnology industry context. However, Enterprise Value should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Enterprise Value mean?
A high Enterprise Value can signal that a stock is expensive relative to its fundamentals. Enterprise value equals the sum of market cap, debt and preferred shares less cash and equivalents. View historical data on Viva Biotech Holdings and its competitors. Viva Biotech Holdings's current Enterprise Value is €293.6 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Viva Biotech Holdings stock overvalued right now?
Based on GuruFocus' analysis, Viva Biotech Holdings (FRA:VB0) is currently considered Significantly Overvalued. The stock's GF Value™ is €0.08, compared to a current price of €0.12 — trading 48.8% above its estimated fair value. The current Enterprise Value is €293.6 Mil. Viva Biotech Holdings' overall GF Score™ is 47/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Enterprise Value calculated?
Enterprise Value is calculated from a company's financial statements. For Viva Biotech Holdings (FRA:VB0), the current Enterprise Value is €293.6 Mil as of Jun. 29, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Viva Biotech Holdings (FRA:VB0) Overvalued in 2026?
Based on GuruFocus' analysis, Viva Biotech Holdings stock appears to be overvalued.
The current stock price of €0.12 is trading 48.8% above its estimated GF Value™ of €0.08.
GuruFocus considers Viva Biotech Holdings to be Significantly Overvalued.
Key valuation signals for FRA:VB0:
Enterprise Value: €293.6 Mil
GF Value™: €0.08 vs. price of €0.12 (48.8% above fair value)
No single metric tells the full story. See the FRA:VB0 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Viva Biotech Holdings is engaged in providing the structure-based drug discovery services to biotechnology and pharmaceutical customers for their pre-clinical stage drug development. The company operates in three reportable segments, Drug Discovery Services providing structure-based drug discovery services to biotechnology and pharmaceutical customers for their pre-clinical stage drug development; Contract Development Manufacture Organisation providing contract development and manufacturing services for small molecule APIs and intermediates and trading of APIs, intermediates and formulations; and commercialisation services; and Viva BioInnovator making strategic investments in biotechnology startup companies.
47GF Score
Get the complete analysis for FRA:VB0
Enterprise Value is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:VB0 has been successfully added to your 
